Ryman Healthcare PE Ratio 1970-1969 | RYHTY
Current and historical p/e ratio for Ryman Healthcare (RYHTY) from 1970 to 1969. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Ryman Healthcare PE ratio as of May 20, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Ryman Healthcare PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
0.00 | nan |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $1.548B | $0.000B |
Ryman Healthcare Limited develops, owns and operates integrated retirement villages, rest homes and hospitals for the elderly principally in New Zealand and Australia. Ryman Healthcare Limited is based in Christchurch, New Zealand. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $127.298B | 15.97 |
Cencora (COR) | United States | $44.302B | 17.27 |
ICON (ICLR) | Ireland | $25.963B | 24.51 |
DiDi Global (DIDIY) | China | $23.233B | 0.00 |
Avantor (AVTR) | United States | $16.975B | 24.99 |
CochLear (CHEOY) | Australia | $14.527B | 0.00 |
Revvity (RVTY) | United States | $13.602B | 23.86 |
Viatris (VTRS) | United States | $13.074B | 3.91 |
Natera (NTRA) | United States | $13.074B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $12.216B | 0.00 |
Medpace Holdings (MEDP) | United States | $12.186B | 40.09 |
Charles River Laboratories (CRL) | United States | $11.415B | 21.85 |
Solventum (SOLV) | United States | $10.774B | 0.00 |
Sonic Healthcare (SKHHY) | Australia | $8.566B | 0.00 |
HealthEquity (HQY) | United States | $6.796B | 50.78 |
Organon (OGN) | United States | $5.606B | 5.32 |
Doximity (DOCS) | United States | $5.229B | 36.40 |
Bausch + Lomb (BLCO) | Canada | $5.150B | 20.63 |
PACS (PACS) | United States | $4.236B | 0.00 |
Surgery Partners (SGRY) | United States | $3.283B | 30.03 |
Sotera Health (SHC) | United States | $3.196B | 15.68 |
Life Times (LTH) | United States | $3.040B | 31.85 |
GoodRx Holdings (GDRX) | United States | $2.807B | 106.86 |
Progyny (PGNY) | United States | $2.675B | 46.05 |
NovoCure (NVCR) | Jersey | $2.366B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.230B | 8.84 |
Agilon Health (AGL) | United States | $2.225B | 0.00 |
Teladoc Health (TDOC) | United States | $2.159B | 0.00 |
Premier (PINC) | United States | $2.061B | 8.82 |
BrightSpring Health Services (BTSG) | United States | $1.965B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.557B | 0.00 | |
Alignment Healthcare (ALHC) | United States | $1.388B | 0.00 |
Embecta (EMBC) | United States | $0.833B | 5.67 |
CareDx (CDNA) | United States | $0.807B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
Pediatrix Medical (MD) | United States | $0.651B | 6.91 |
Auna S.A (AUNA) | Luxembourg | $0.645B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.585B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.536B | 0.00 |
InnovAge Holding (INNV) | United States | $0.503B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.448B | 0.00 |
Enhabit (EHAB) | United States | $0.414B | 41.25 |
ModivCare (MODV) | United States | $0.391B | 7.32 |
MultiPlan (MPLN) | United States | $0.380B | 0.00 |
Beauty Health (SKIN) | United States | $0.338B | 0.00 |
LifeMD (LFMD) | United States | $0.329B | 0.00 |
DocGo (DCGO) | United States | $0.313B | 17.11 |
Sharecare (SHCR) | United States | $0.310B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.277B | 0.00 |
Sera Prognostics (SERA) | United States | $0.270B | 0.00 |
Biodesix (BDSX) | United States | $0.181B | 0.00 |
So-Young (SY) | China | $0.122B | 41.00 |
Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
NeueHealth (NEUE) | United States | $0.049B | 6.66 |
Oncology Institute (TOI) | United States | $0.047B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
Nutex Health (NUTX) | United States | $0.035B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.029B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.028B | 0.00 |
OncoCyte (OCX) | United States | $0.024B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.024B | 0.00 |
DermTech (DMTK) | United States | $0.017B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.007B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
OpGen (OPGN) | United States | $0.006B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
Assure Holdings (IONM) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |